Please provide your email address to receive an email when new articles are posted on . Semaglutide and tirzepatide not only reduce body weight in obesity but are also approved to treat other ...
The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...
Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...
The Trump administration’s proposed cuts to medical research and health agencies will curtail the development of promising medications, the Congressional Budget Office said on Friday. By Benjamin ...
The pharmaceutical industry is experiencing its own “DeepSeek moment,” according to science writer Hiya Jain. Just as the upstart AI breakthrough caught Silicon Valley off-guard, China is emerging as ...
The Congressional Budget Office (CBO) informs Congress about the costs or revenue changes associated with proposed legislation, a challenging enough task on its own. Sometimes, the CBO is asked to ...
Biotech companies developing drugs for hard-to-treat diseases and other ailments are being forced to push back clinical trials and drug testing in the wake of mass layoffs at the Food and Drug ...
April 10 (Reuters) - The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with "human-relevant ...
The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before. The data come from 20 pharmas that had the highest R&D budgets in 2020, as ...
It’s always a high-stakes gamble in the pharmaceutical industry to develop a new drug. The process typically takes 10 to 15 years and requires extensive testing, regulatory approval, and clinical ...
Budget and staffing cuts at the Food and Drug Administration orchestrated by President Donald Trump could prevent new drugs “from being developed, approved, or commercialized in a timely manner, or at ...
When Genentech licensed experimental drug vixarelimab from Kiniksa Pharmaceuticals KNSA2.83%increase; green up pointing triangle, its scientists thought they had a future lung medicine in their hands.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback